Key result
Integrated cardiopulmonary evaluation guides transcatheter ASD closure in ~88% of patients with airway disease safely.
Why the study?
Dyspnea in adults with secundum ASD is often attributed solely to shunt physiology, leaving coexisting airway disease unrecognized. Conversely, clinically significant ASD may be overlooked in patients presenting primarily with respiratory symptoms, creating a bidirectional diagnostic blind spot.
Does integrated cardiopulmonary evaluation and preprocedural respiratory optimization improve symptom attribution and guide individualized transcatheter ASD closure in adults with secundum ASD and coexisting airway disease?
Observational (n=8)
No
Does integrated cardiopulmonary evaluation and preprocedural respiratory optimization improve symptom attribution and guide individualized transcatheter ASD closure in adults with secundum ASD and coexisting airway disease?
In adults with secundum ASD and disproportionate dyspnea, integrated cardiopulmonary evaluation and preprocedural respiratory optimization can uncover coexisting airway disease, clarify symptom attribution, and individualize transcatheter closure strategies (including fenestrated closure or deferral of intervention).
Answers are grounded in this paper and cite their sources.
May support individualized ASD closure decisions with airway disease; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: Dyspnea in adults with secundum atrial septal defect (ASD) is often attributed to shunt physiology, whereas coexisting airway disease may remain unrecognized. Conversely, clinically significant ASD may be overlooked in patients presenting with predominant respiratory symptoms, creating a bidirectional cardiopulmonary diagnostic blind spot. CASE SUMMARY: We retrospectively identified 8 adults (median age 55.5 years; 5 women) with secundum ASD (15-30 mm) and clinically significant airway disease through bidirectional cardiology-pulmonology referral (6 cardiology-to-pulmonology; 2 pulmonology-to-cardiology). Airway physiology was obstructive in 6, restrictive in 1, and mixed in 1, with bronchodilator reversibility in 5. Integrated cardiopulmonary evaluation and respiratory optimization improved symptom attribution and guided individualized management. Seven patients underwent transcatheter ASD closure (median device size, 38 mm), including fenestrated closure in 2 after balloon occlusion testing identified impaired left ventricular compliance; 1 deferred closure after symptomatic improvement with respiratory therapy alone. No procedural complications occurred, and 1 noncardiac death occurred 5 years after intervention. TAKE-HOME MESSAGES: Dyspnea in adults with ASD may reflect combined cardiac and airway disease. Disproportionate symptoms should prompt integrated cardiopulmonary evaluation. Accurate symptom attribution underpins respiratory optimization and individualized ASD closure.
No takes yet. Share an insight, caveat, or question.
Chakraborti et al. (2026) conducted an observational in Secundum atrial septal defect (ASD) and coexisting clinically significant airway disease (n=8). Integrated cardiopulmonary evaluation, targeted respiratory optimization, and individualized transcatheter ASD closure was evaluated on Clinical management strategy, procedural success of transcatheter ASD closure, and symptomatic improvement. Integrated cardiopulmonary evaluation guided management in 8 adults with ASD and airway disease, leading to transcatheter closure in 87.5% with 0% procedural complications.
Synapse has enriched 10 related papers. Consider them for comparative context: